0000902664-23-003407.txt : 20230602 0000902664-23-003407.hdr.sgml : 20230602 20230602173520 ACCESSION NUMBER: 0000902664-23-003407 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230531 FILED AS OF DATE: 20230602 DATE AS OF CHANGE: 20230602 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nichols Weston CENTRAL INDEX KEY: 0001746376 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23990379 MAIL ADDRESS: STREET 1: C/O CRINETICS PHARMACEUTICALS, INC. STREET 2: 10222 BARNES CANYON ROAD, BLDG. #2 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynx1 Capital Management LP CENTRAL INDEX KEY: 0001910456 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40603 FILM NUMBER: 23990380 BUSINESS ADDRESS: STREET 1: 151 CALLE DE SAN FRANCISCO STREET 2: SUITE 200 PMB 1237 CITY: SAN JUAN STATE: PR ZIP: 00901-1607 BUSINESS PHONE: 703-963-7214 MAIL ADDRESS: STREET 1: 151 CALLE DE SAN FRANCISCO STREET 2: SUITE 200 PMB 1237 CITY: SAN JUAN STATE: PR ZIP: 00901-1607 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TScan Therapeutics, Inc. CENTRAL INDEX KEY: 0001783328 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 825282075 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 857-399-9500 MAIL ADDRESS: STREET 1: 880 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0407 4 2023-05-31 0 0001783328 TScan Therapeutics, Inc. TCRX 0001910456 Lynx1 Capital Management LP 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 PUERTO RICO 0 0 1 0 0001746376 Nichols Weston 151 CALLE DE SAN FRANCISCO SUITE 200 PMB 1237 SAN JUAN PR 00901-1607 PUERTO RICO 0 0 1 0 0 Common stock, $0.0001 par value per share Common Stock 2023-05-31 4 S 0 10000 2.5148 D 5240000 I See footnote Common Stock 2023-05-31 4 S 0 15000 2.5201 D 5225000 I See footnote Common Stock 2023-05-31 4 S 0 400 2.5075 D 5224600 I See footnote The securities to which this filing relates are held directly by Lynx1 Master Fund LP to which Lynx1 Capital Management LP (the "Investment Manager") serves as investment manager. Weston Nichols ("Mr. Nichols") is the sole member of Lynx1 Capital Management GP LLC, the general partner of the Investment Manager. Each of the Investment Manager and Mr. Nichols disclaims beneficial ownership of the securities to which this filing relates for purposes of ection 16 of the Securities and Exchange Act of 1934, as amended, except to the extent of his or its pecuniary interest therein, if any. Lynx1 Capital Management LP, By: Lynx1 Capital Management GP LLC, its general partner, By: /s/ Weston Nichols, Sole Member 2023-06-02 /s/ Weston Nichols 2023-06-02